Your Article Summary
Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis
Journal of Cystic Fibrosis , 06/26/09
Cohen-Cymberknoh M et al. - High-dose IV-pulse methylprednisolone is an effective treatment for ABPA in CF with minor side effects.
Related Articles
Diabetes as a Determinant of Mortality in Cystic Fibrosis
Diabetes Care, 11/20/09
Relevance Score: 69%
Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09
Relevance Score: 69%
Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09
Relevance Score: 69%
Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09
Relevance Score: 69%
Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation
Evidence-Based Medicine, 12/07/09
4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta-analysis and Cost-Effectiveness Study That Focuses on Compliance and Liver Toxicity
Clinical Infectious Diseases, 12/07/09
Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults
Antimicrobial Agents and Chemotherapy, 12/07/09
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Smoking-related Lung Disease
Journal of Thoracic Imaging, 12/07/09
Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients
Clinical Microbiology and Infection, 12/07/09
Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R
Health and Quality of Life Outcomes , 12/07/09

See Latest Articles